论文信息 - Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma - 字舞流文

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Rachel A. Kudgus | S. Groshen | J. Maris | K. Matthay | H. Shimada | J. Courtier | Y. Mossé | S. Cohn | J. Reid | L. Wagner | G. Yanik | R. Bagatell | F. Goodarzian | H. Lai | Julie R. Park | R. McGovern | S. DuBois | D. Tsao-Wei | M. Granger | S. Czarnecki | K. Goldsmith | B. Weiss | C. Twist | A. Marachelian | E. Fox | M. Macy | R. Hawkins | N. Boucher | Chunqiao Luo | Kelly C. Goldsmith | Rachel A Kudgus